Effect of Hydralazine on Alzheimer's Disease
Condition: Alzheimer Disease Interventions: Drug: Hydralazine hydrochloride 25mg tablets; Drug: Placebo Sponsors: Shahid Sadoughi University of Medical Sciences and Health Services; National Institute for Medical Research Development (NIMAD), Iran; McMaster University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials